Double-hit and triple-hit lymphomas arising from follicular lymphoma following acquisition of MYC: Report of two cases and literature review

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 4, 2013, Pages 788-794

  Xu, Xiaoxiao ^a   Zhang, Le ^a   Wang, Yafei ^a   Zhang, Qing ^a   Zhang, Lianyu ^a   Sun, Baocun ^a   Zhang, Yizhuo ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

BCL2; BCL6; Cases report; Double hit; Follicular lymphoma; MYC

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; MYC PROTEIN; MYC PROTEIN, HUMAN; PREDNISONE; R CHOP PROTOCOL; R-CHOP PROTOCOL; VINCRISTINE;

ADULT; ARTICLE; B CELL LYMPHOMA; BCL2; BCL6; CASE REPORT; CASES REPORT; CELL TRANSFORMATION; DOUBLE HIT; FEMALE; FOLLICULAR LYMPHOMA; GENE TRANSLOCATION; GENETICS; HUMAN; METABOLISM; MIDDLE AGED; MYC; RADIOTHERAPY; TREATMENT OUTCOME; WHOLE BODY RADIATION;

BCL2; BCL6; CASES REPORT; DOUBLE HIT; FOLLICULAR LYMPHOMA; MYC;

ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL TRANSFORMATION, NEOPLASTIC; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FEMALE; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, FOLLICULAR; METHYLPREDNISOLONE; MIDDLE AGED; PREDNISONE; PROTO-ONCOGENE PROTEINS C-MYC; RADIOTHERAPY; TRANSLOCATION, GENETIC; TREATMENT OUTCOME; VINCRISTINE; WHOLE-BODY IRRADIATION;

EID: 84883039274     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Tsujimoto Y, Cossman J, Jaffe E, Croce CM. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985; 228: 1440-3.
2. Barrans S, Crouch S, Smith A, Turner K, Owen R, Patmore R, Roman E, Jack A. Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab. J Clin Oncol 2010; 28: 3360-5.
3. Aukema SM, Siebert R, Schuuring E, van Imhoff GW, Kluin-Nelemans HC, Boerma EJ, Kluin PM. Double-hit B-cell lymphomas. Blood 2011; 117: 2319-31.
4. Motllo C, Grau J, Junca J, Ruiz N, Mate JL, Orna E, Navarro JT, Vives S, Sancho JM, Esteban D, Granada I, Feliu E, Ribera JM, Milla F. Translocation (3;8)(q27;q24) in two cases of triple hit lymphoma. Cancer Genet Cytogenet 2010; 203: 328-32.
5. Lin P, Medeiros LJ. High-grade B-cell lymphoma/ leukemia associated with t(14;18) and 8q24/MYC rearrangement: a neoplasm of germinal center immunophenotype with poor prognosis. Haematologica 2007; 92: 1297-301.
6. Johnson NA, Savage KJ, Ludkovski O, Ben-Neriah S, Woods R, Steidl C, Dyer MJ, Siebert R, Kuruvilla J, Klasa R, Connors JM, Gascoyne RD, Horsman DE. Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. Blood 2009; 114: 2273-9.
7. Boerma EG, Siebert R, Kluin PM, Baudis M. Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge. Leukemia 2009; 23: 225-34.
8. Christie L, Kernohan N, Levison D, Sales M, Cunningham J, Gillespie K, Batstone P, Meiklejohn D, Goodlad J. C-MYC translocation in t(14;18) positive follicular lymphoma at presentation: An adverse prognostic indicator?. Leuk Lymphoma 2008; 49: 470-6.
9. Au WY, Gascoyne RD, Viswanatha DS, Skinnider BF, Connors JM, Klasa RJ, Horsman DE. Concurrent chromosomal alterations at 3q27, 8q24 and 18q21 in B-cell lymphomas. Br J Haematol 1999; 105: 437-40.
10. Macpherson N, Lesack D, Klasa R, Horsman D, Connors JM, Barnett M, Gascoyne RD. Small noncleaved, non-Burkitt's (Burkit-Like) lymphoma: cytogenetics predict outcome and reflect clinical presentation. J Clin Oncol 1999; 17: 1558-67.
11. Le Gouill S, Talmant P, Touzeau C, Moreau A, Garand R, Juge-Morineau N, Gaillard F, Gastinne T, Milpied N, Moreau P, Harousseau JL, Avet-Loiseau H. The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement. Haematologica 2007; 92: 1335-42.
12. Young KH, Xie Q, Zhou G, Eickhoff JC, Sanger WG, Aoun P, Chan WC. Transformation of follicular lymphoma to precursor B-cell lymphoblastic lymphoma with c-myc gene rearrangement as a critical event. Am J Clin Pathol 2008; 129: 157-66.
13. Tanaka H, Hashimoto S, Abe D, Sakai S, Takagi T. Double-hit lymphoma at second relapse of Burkitt-like lymphoma: a case report. J Clin Exp Hematop 2011; 51: 43-7.
14. Marin MC, Hsu B, Stephens LC, Brisbay S, Mc-Donnell TJ. The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo. Exp Cell Res 1995; 217: 240-7.
15. Kornblau SM, Goodacre A, Cabanillas F. Chromosomal abnormalities in adult non-endemic Burkitt's lymphoma and leukemia: 22 new reports and a review of 148 cases from the literature. Hematol Oncol 1991; 9: 63-78.
16. Pedersen MO, Gang AO, Poulsen TS, Knudsen H, Lauritzen AF, Nielsen SL, Gang UO, Norgaard P. Double-hit BCL2/MYC translocations in a consecutive cohort of patients with large B-cell lymphoma -a single centre's experience. Eur J Haematol 2012; 89: 63-71.
17. Savage KJ, Johnson NA, Ben-Neriah S, Connors JM, Sehn LH, Farinha P, Horsman DE, Gascoyne RD. MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with RCHOP chemotherapy. Blood 2009; 114: 3533-7.
18. Klapper W, Stoecklein H, Zeynalova S, Ott G, Kosari F, Rosenwald A, Loeffler M, Trumper L, Pfreundschuh M, Siebert R. Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). Leukemia 2008; 22: 2226-9.
19. Elkins CT, Wakely PJ. Cytopathology of "doublehit" non-Hodgkin lymphoma. Cancer Cytopathol 2011; 119: 263-71.
20. Niitsu N, Okamoto M, Miura I, Hirano M. Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC translocations. Leukemia 2009; 23: 777-83.
21. Tomita N, Tokunaka M, Nakamura N, Takeuchi K, Koike J, Motomura S, Miyamoto K, Kikuchi A, Hyo R, Yakushijin Y, Masaki Y, Fujii S, Hayashi T, Ishigatsubo Y, Miura I. Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations. Haematologica 2009; 94: 935-43.
22. Munoz J, Vekaria M, Hanbali A, Janakiraman N. Progression of double-hit lymphoma in the midst of R-hyper CVAD. Am J Hematol 2013; 88: 87-8.
23. Parker SM, Olteanu H, Vantuinen P, Lawton CA, Schultz CJ, Christians KK, Fenske TS. Follicular lymphoma transformation to dual translocated Burkitt-like lymphoma: improved disease control associated with radiation therapy. Int J Hematol 2009; 90: 616-22.